Liu Jie, Gong Tao, Wang Changguang, Zhong Zhirong, Zhang Zhirong
Key Laboratory of Drug Targeting, Ministry of Education, Sichuan University, No. 17, Section 3, Southern Renmin Road, Chengdu, Sichuan 610041, PR China.
Int J Pharm. 2007 Aug 1;340(1-2):153-62. doi: 10.1016/j.ijpharm.2007.03.009. Epub 2007 Mar 12.
Solid lipid nanoparticles (SLNs) loaded with insulin-mixed micelles (Ins-MMs) were prepared by a novel reverse micelle-double emulsion method, in which sodium cholate (SC) and soybean phosphatidylcholine (SPC) were employed to improve the liposolubility of insulin, and the mixture of stearic acid and palmitic acid were employed to prepare insulin loaded solid lipid nanoparticles (Ins-MM-SLNs). Some of the formulation parameters were optimized to obtain high quality nanoparticles. The particle size and zeta potential measured by photon correlation spectroscopy (PCS) were 114.7+/-4.68 nm and -51.36+/-2.04 mV, respectively. Nanospheres observed by transmission electron microscopy (TEM) and scanning electron microscopy (SEM) showed extremely spherical shape. The entrapment efficiency (EE%) and drug loading capacity (DL%) determined with high performance liquid chromatogram (HPLC) by modified ultracentrifuge method were 97.78+/-0.37% and 18.92+/-0.07%, respectively. Differential scanning calorimetry (DSC) of Ins-MM-SLNs indicated no tendency of recrystallisation. The core-shell drug loading pattern of the SLNs was confirmed by fluorescence spectra and polyacrylamide gel electrophoresis (PAGE) which also proved the integrity of insulin after being incorporated into lipid carrier. The drug release behavior was studied by in situ and externally sink method and the release pattern of drug was found to follow Weibull and Higuchi equations. Results of stability evaluation showed a relatively long-term stability after storage at 4 degrees C for 6 months. In conclusion, SLNs with small particle size, excellent physical stability, high entrapment efficiency, good loading capacity for protein drug can be produced by this novel reverse micelle-double emulsion method in present study.
采用新型反胶束 - 双乳液法制备了负载胰岛素混合胶束(Ins - MMs)的固体脂质纳米粒(SLNs),其中使用胆酸钠(SC)和大豆磷脂酰胆碱(SPC)提高胰岛素的脂溶性,并用硬脂酸和棕榈酸的混合物制备负载胰岛素的固体脂质纳米粒(Ins - MM - SLNs)。对一些制剂参数进行了优化以获得高质量的纳米粒。通过光子相关光谱法(PCS)测得的粒径和zeta电位分别为114.7±4.68 nm和 - 51.36±2.04 mV。通过透射电子显微镜(TEM)和扫描电子显微镜(SEM)观察到的纳米球呈现出极其规则的球形。采用改良超速离心法结合高效液相色谱(HPLC)测定的包封率(EE%)和载药量(DL%)分别为97.78±0.37%和18.92±0.07%。Ins - MM - SLNs的差示扫描量热法(DSC)表明没有重结晶趋势。通过荧光光谱和聚丙烯酰胺凝胶电泳(PAGE)证实了SLNs的核壳载药模式,这也证明了胰岛素掺入脂质载体后其完整性。通过原位和外源性漏槽法研究了药物释放行为,发现药物释放模式符合威布尔和 Higuchi 方程。稳定性评估结果表明,在4℃储存6个月后具有相对长期的稳定性。总之,本研究通过这种新型反胶束 - 双乳液法可以制备出粒径小、物理稳定性优异、包封率高、对蛋白质药物载药量良好的SLNs。